标题
Overcoming bortezomib resistance in multiple myeloma
作者
关键词
-
出版物
BIOCHEMICAL SOCIETY TRANSACTIONS
Volume 42, Issue 4, Pages 804-808
出版商
Portland Press Ltd.
发表日期
2014-08-11
DOI
10.1042/bst20140126
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Boldly Targeting Kinases without mutations
- (2014) M. S. Davids BLOOD
- Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
- (2014) Jens G. Lohr et al. CANCER CELL
- Egress of CD19+CD5+ cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients
- (2013) B. Y. Chang et al. BLOOD
- Identification of Bruton's tyrosine kinase as a therapeutic target in acute myeloid leukemia
- (2013) S. A. Rushworth et al. BLOOD
- The Bruton tyrosine kinase (BTK) inhibitor PCI-32765 synergistically increases proteasome inhibitor activity in diffuse large-B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomib
- (2013) Girija Dasmahapatra et al. BRITISH JOURNAL OF HAEMATOLOGY
- Why Proteasome Inhibitors Cannot ERADicate Multiple Myeloma
- (2013) Robert Z. Orlowski CANCER CELL
- Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma
- (2013) Chungyee Leung-Hagesteijn et al. CANCER CELL
- A Preclinical Assay for Chemosensitivity in Multiple Myeloma
- (2013) Z. P. Khin et al. CANCER RESEARCH
- Bruton’s Tyrosine Kinase (BTK) Inhibitors in Clinical Trials
- (2013) Jan A. Burger Current Hematologic Malignancy Reports
- Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma
- (2012) B. A. Walker et al. BLOOD
- The high Nrf2 expression in human acute myeloid leukemia is driven by NF- B and underlies its chemo-resistance
- (2012) S. A. Rushworth et al. BLOOD
- Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma
- (2012) Y.-T. Tai et al. BLOOD
- Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides
- (2012) J. B. Egan et al. BLOOD
- Clonal competition with alternating dominance in multiple myeloma
- (2012) J. J. Keats et al. BLOOD
- Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma
- (2012) D. J. Kuhn et al. BLOOD
- Bortezomib induces heme oxygenase-1 expression in multiple myeloma
- (2012) Lawrence N. Barrera et al. CELL CYCLE
- BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-κB
- (2012) Stuart A. Rushworth et al. CELLULAR SIGNALLING
- High Basal Nuclear Levels of Nrf2 in Acute Myeloid Leukemia Reduces Sensitivity to Proteasome Inhibitors
- (2011) S. A. Rushworth et al. CANCER RESEARCH
- Treatment Options for Relapsed and Refractory Multiple Myeloma
- (2011) Sagar Lonial et al. CLINICAL CANCER RESEARCH
- Bruton's Tyrosine Kinase Is Required for TLR-Dependent Heme Oxygenase-1 Gene Activation via Nrf2 in Macrophages
- (2011) V. Vijayan et al. JOURNAL OF IMMUNOLOGY
- Initial genome sequencing and analysis of multiple myeloma
- (2011) Michael A. Chapman et al. NATURE
- IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms
- (2010) E. De Bruyne et al. BLOOD
- Neutrophil development and function critically depend on Bruton tyrosine kinase in a mouse model of X-linked agammaglobulinemia
- (2010) K. Fiedler et al. BLOOD
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Primary therapy with single agent bortezomib as induction, maintenance and re-induction in patients with high-risk myeloma: results of the ECOG E2A02 trial
- (2010) A Dispenzieri et al. LEUKEMIA
- Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells
- (2010) Stephanie Markovina et al. Molecular Cancer
- Multiple myeloma
- (2009) Marc S Raab et al. LANCET
- Molecular basis of bortezomib resistance: proteasome subunit 5 (PSMB5) gene mutation and overexpression of PSMB5 protein
- (2008) R. Oerlemans et al. BLOOD
- The Tec Family Tyrosine Kinase Btk Regulates RANKL-induced Osteoclast Maturation
- (2008) Seoung Hoon Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bortezomib-Resistant Nuclear Factor- B Activity in Multiple Myeloma Cells
- (2008) S. Markovina et al. MOLECULAR CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search